Technical Product Manager

DexCare acquires Mila Health, extending AI agents from scheduling to care coordination. October 2, 2026 Combined Platform Pairs Agentic AI with Governed Data to Close Care Gaps, Coordinate Complex Cases, and Complete Multi-Step Patient Journeys DexCare, Inc. today announced the acquisition of Mila Health (Mila), an AI care coordination company whose agents call, text, and chat with patients to get them scheduled, prepared, and seen. Mila runs on DexCare's access data model - proven across more than 10 million bookings - which standardizes scheduling data and institutional know-how into one rulebook for any service line, under the health system's control. "Mila gives our data a voice, and our data gives Mila direction," said Matt Blosl, CEO at DexCare. "AI solutions are everywhere, but health systems quickly realize that building the infrastructure, scaling the pilot, and managing the agent's boundaries is untenable. Most agents lack contextual awareness to connect a health system, to know the relationships between service lines and the nuances and preferences of staff, locations, and providers. Any agent can sound incredibly human, but ours understands the health system it speaks for." "With Mila, DexCare pairs our access data model - the intelligence that controls where, when, and how to navigate a patient - with agents that act on it, from calling someone who's overdue for a visit, to walking them through what a procedure requires, and checking in once they're home," added Blosl. "The era of stitching together tools, one at a time, to solve one access challenge is over." DexCare's platform connects disjointed data and knowledge into a rulebook that governs patient access. Credentialing, referral requirements, insurance, and scheduling protocols vary by location, provider, and scheduler, and DexCare reconciles them before a conflict reaches a patient. Mila's agents draw on approved workflows to answer the questions that decide a visit, like whose slot is open, whether the patient qualifies, and whether a closer or more appropriate option exists. "Many scheduling technologies work for simple visits, but they struggle when clinical requirements and scheduling rules become more complex," said Dr. Peter Chang, Senior Vice President and Chief Transformation Officer at Tampa General Hospital. "DexCare efficiently codified 260 scheduling policies and uncovered more than 50 gaps. Bringing scheduling and clinical logic together in a single system enables AI to accurately coordinate complex specialty care, not just for one clinic, but expanded across our entire enterprise." Mila works with payers, providers, and software systems. In production, its agents achieve a 54% patient response rate during outbound outreach, which is 80% higher than manual call centers. Mila agents reduce no-show rates by 50% and increase revenue by 18%. "Healthcare can't rely on out-of-the-box large language models because they're unpredictable and can't be audited," said Shailu Verma, Co-Founder and CEO at Mila Health. "With DexCare, providers and payers can configure an AI agent to complete the tasks they can't staff for and trace how it decided each step. Mila solves more and escalates less, so leaders can place their people on the work that needs a person." Mila transforms manual coordination work into completed action, operating within the systems that payers, providers, and health-technology teams use. Mila is designed as an API-first system that can be configured, governed and embedded into existing workflows to launch AI agents in hours. The deal is DexCare's second acquisition. DexCare spun out of Providence Health in 2021. The company has raised $146 million to date, including a $75 million Series C round led by ICONIQ Growth in 2023, and acquired Womp, Inc. in 2022 to bring consumer-grade search and scheduling to healthcare. DexCare ranked No. 1 for patient experience in KLAS's 2025 Emerging Solutions Top 20 report. About DexCare Better data. For better access. DexCare is a patient navigation company and the system of record for access. Our data model unifies EHRs, workflows, and staff knowledge into one governed platform that codifies policies and orchestrates patients by need, location, and capacity. DexCare replaces the stack of point solutions powering your website, search, call center, and AI agents. We find the patient searching and the one overdue, then schedule, prepare, and follow through. Customers book 40 percent more appointments with existing resources and cut time to care by five days. Built inside Providence, DexCare serves 57 million patients across 50 states, with customers including Kaiser Permanente, Piedmont, Texas Health Resources, and Tampa General. Visit dexcare.com. Originally announced September 21st, 2026

DexCare buys AI scheduling startup Mila Health. Seattle-based health-tech company DexCare has acquired Mila Health, a local startup specializing in AI-driven patient appointment scheduling. The deal, announced today, combines DexCare's existing scheduling infrastructure with Mila's AI agents designed to handle appointment inquiries via call and text. DexCare, which originated from Providence's digital innovation team a decade ago, currently manages appointment workflows for 57 million patients across the U.S., including major systems like Kaiser Permanente and Texas Health Resources. Its platform handles referrals, insurance verification, and scheduling protocols - areas where Mila's AI can now integrate more deeply. Mila's technology stands out by embedding AI agents into existing healthcare systems within hours, according to the company. Unlike generic large language models, these agents are configurable to specific tasks, such as qualifying patients for appointments, and can be audited for compliance, a key concern in healthcare. "Healthcare can't rely on out-of-the-box large language models because they're unpredictable and can't be audited," said Shailu Verma, co-founder and CEO of Mila. "With DexCare, providers and payers can configure an AI agent to complete the tasks they can't staff for." DexCare's CEO, Matt Blosl, noted that while AI solutions are widespread, scaling them for healthcare presents challenges. The company's infrastructure already supports 133 employees and has raised $146 million, including a $75 million round in 2023. It previously acquired Womp, a Bellingham-based e-commerce platform, in 2022. Mila, founded in January 2024, has 25 employees and has not raised venture capital, though it participated in the Advanced Technology Development Center accelerator. Verma previously led product strategy at UnitedHealth Group and worked at Amazon Web Services for five years. The combined company could address a persistent gap in healthcare: automating repetitive scheduling tasks while maintaining compliance. Hospitals often struggle with no-show rates and underutilized appointment slots, and AI agents may help optimize both. Still, adoption will depend on how well the merged platform balances speed with accuracy, a test for any AI-driven healthcare tool. DexCare was named a finalist for the 2023 Health Innovation of the Year award and ranks No. 43 on GeekWire's list of top Pacific Northwest startups. The acquisition does not include disclosed financial terms.